Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection

Viral Immunology

Volumn 21, Issue 3, 2008, Pages 327-338

  Moore, Martin L ^a   Chi, Michael H ^a   Goleniewska, Kasia ^a   Durbin, Joan E ^b,c   Peebles Jr , R Stokes ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GANGLIOTETRAOSYLCERAMIDE; SPHINGOLIPID ACTIVATOR PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BAGG ALBINO MOUSE; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL SELECTION; COMPLEMENT ALTERNATIVE PATHWAY; CONFERENCE PAPER; DISEASE PREDISPOSITION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; IMMUNOREGULATION; LIPID RAFT; LYMPHOCYTE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; WILD TYPE;

ANIMALS; CELL LINE; FEMALE; G(M1) GANGLIOSIDE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; VIRAL LOAD; VIRUS REPLICATION;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 51849156554     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2008.0003     Document Type: Conference Paper

References (62)

1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, and Anderson LJ: Bronchiolitis-associated hospitalizations among U.S. children, 1980-1996. JAMA 1999; 282:1440-1446.
2. Moore ML, and Peebles RS Jr: Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacol Ther 2006;112:405-424.
3. Tripp RA, Moore D, Barskey A, Jones L, Moscatiello C, Keyserling H, and Anderson LJ: Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. J Infect Dis 2002;185:1388-1394.
4. Glezen WP, Taber LH, Frank AL, and Kasel JA: Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543-546.
5. Anderson JJ, Norden J, Saunders D, Toms GL, and Scott R: Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection. J Gen Virol 1990;71(Pt 7):1561-1570.
6. Graham BS, Johnson TR, and Peebles RS: Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 2000;48:237-247.
7. Hussell T, and Openshaw PJ: Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. J Gen Virol 1998;79(Pt 11):2593-2601.
8. Graham BS, Bunton LA, Wright PF, and Karzon DT: Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991;88:1026-1033.
9. Bangham CR, Cannon MJ, Karzon DT, and Askonas BA: Cytotoxic T-cell response to respiratory syncytial virus in mice. J Virol 1985;56:55-59.
10. Cannon M J, Openshaw PJ, and Askonas BA: Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 1988;168:1163-1168.
11. Ostler T, Davidson W, and Ehl S: Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma. Eur J Immunol 2002;32:2117-2123.
12. Hall CB: Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-1928.
13. Legg JP. Hussain IR, Warner JA, Johnston SL, and Warner JO: Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003;168:633-639.
14. Cederblad B, Riesenfeld T, and Alm GV: Deficient herpes simplex virus-induced interferon-alpha production by blood leukocytes of preterm and term newborn infants. Pediatr Res 1990;27:7-10.
15. Neustock P, Kruse A, Bock S, St Pierre B, and Kirchner H: Deficient interferon-alpha response of newborns in comparison to adults. Lymphokine Cytokine Res 1993;12:109-114.
16. Durbin JE, Hackenmiller R, Simon MC, and Levy DE: Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996;84:443-450.
17. Fallarino F, and Gajewski TF: Cutting edge: differentiation of antitumor CTL in vivo requires host expression of Stat1. J Immunol 1999;163:4109-4113.
18. Lee CK, Rao DT, Gertner R, Gimeno R, Frey AB, and Levy DE: Distinct requirements for IFNs and STAT1 in NK cell function. J Immunol 2000;165:3571-3577.
19. Nishibori T, Tanabe Y, Su L, and David M: Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: Increased susceptibility to autoimmune disease. J Exp Med 2004;199:25-34.
20. Durbin JE, Fernandez-Sesma A, Lee CK, et al.: Type I IFN modulates innate and specific antiviral immunity. J Immunol 2000;164:4220-4228.
21. Hashimoto K, Durbin JE, Zhou W, et al.: Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J Allergy Clin Immunol 2005;116:550-557.
22. Degroote S, Wolthoorn J, and van Meer G: The cell biology of glycosphingolipids. Semin Cell Dev Biol 2004;15:375-387.
23. Proia RL: Glycosphingolipid functions: insights from engineered mouse models. Philos Trans R Soc Lond B Biol Sci 2003;358:879-883.
24. Allende ML, and Proia RL: Lubricating cell signaling pathways with gangliosides. Curr Opin Struct Biol 2002;12:587-592.
25. Hakomori SI: Inaugural article: The glycosynapse. Proc Natl Acad Sci USA 2002;99:225-232.
26. Dykstra M, Cherukuri A, Sohn HW, Tzeng SJ, and Pierce SK: Location is everything: lipid rafts and immune cell signaling. Annu Rev Immunol 2003;21:457-481.
27. Simons K, and Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-39.
28. Brown DA, and Rose JK: Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992;68:533-544.
29. Gomez-Mouton C, Abad JL, Mira E, et al.: Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci USA 2001;98:9642-9647.
30. Tani-ichi S, Maruyama K, Kondo N, et al.: Structure and function of lipid rafts in human activated T cells. Int Immunol 2005;17:749-758.
31. Mori T, Kiyokawa N, Katagiri YU, et al.: Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells. Exp Hematol 2000;28:1260-1268.
32. Smith DC, Lord JM, Roberts LM, and Johannes L: Glycosphingolipids as toxin receptors. Semin Cell Dev Biol 2004;15:397-408.
33. Soong G, Reddy B, Sokol S, Adamo R, and Prince A: TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest 2004;113:1482-1489.
34. Bukowski JF, Woda BA, Habu S, Okumura K, and Welsh RM: Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983; 131:1531-1538.
35. Bukowski JF, Woda BA, and Welsh RM: Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol 1964;52:119-128.
36. Bukowski JF, and Welsh RM: The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J Immunol 1986;136:3481-3485.
37. Byrne P, McGuirk P, Todryk S, and Mills KH: Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol 2004;34:2579-2588.
38. Godeny EK, and Gauntt CJ: Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol 1986;137:1695-1702.
39. Iwanami N, Niwa A, Yasutomi Y, Tabata N, and Miyazawa M: Role of natural killer cells in resistance against friend retrovirus-induced leukemia. J Virol 2001;75:3152-3163.
40. Junqueira-Kipnis AP, Kipnis A, Jamieson A, et al.: NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J Immunol 2003;171:6039-6045.
41. Liu ZX, Govindarajan S, Okamoto S, and Dennert G: NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol 2000;164:6480-6486.
42. Muhlen KA, Schumann J, Wittke F, Stenger S, Van Rooijen N, Van Kaer L, and Tiegs G: NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J Immunol 2004;172:3034-3041.
43. Stein-Streilein J, and Guffee J: In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J Immunol 1988;136:1435-1441.
44. Warfield KL, Perkins JG, Swenson DL, et al.: Role of natural killer cells in innate protection against lethal Ebola virus infection. J Exp Med 2004;200:169-179.
45. Yang H, Yogeeswaran G, Bukowski JF, and Welsh RM: Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice. Nat Immun Cell Growth Regul 1985;4:21-39.
46. Chen XP, Enioutina EY, and Daynes RA: The control of IL-4 gene expression in activated murine T lymphocytes: a novel role for neu-1 sialidase. J Immunol 1997;158:3070-3080.
47. Scalzo AA, Farrell HE, and Karupiah G: Techniques for studying murine natural killer cells in defense against viral infection, in: Methods in Molecular Biology, Vol. 121: Natural Killer Cell Protocols: Cellular and Molecular Methods. (KS Campbell and M Colonna), (eds.). Humana Press, Totowa, NJ, 2000, pp. 163-177.
48. Slifka MK, Pagarigan RR, and Whitton JL: NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol 2000;164:2009-2015.
49. Stitz L, Baenziger J, Pircher H, Hengartner H, and Zinkernagel RM: Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. J Immunol 1986;136:4674-4680.
50. Brown G, Rixon HW, and Sugrue RJ: Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1. J Gen Virol 2002;83:1841-1850.
51. Brown G, Jeffree CE, McDonald T, Rixon HW, Aitken JD, and Sugrue RJ: Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection. Virology 2004;327:175-185.
52. Brown G, Rixon HW, Steel J, McDonald TP, Pitt AR, Graham S, and Sugrue RJ: Evidence for an association between heat shock protein 70 and the respiratory syncytial virus polymerase complex within lipid-raft membranes during virus infection. Virology 2005;338:69-80.
53. McCurdy LH, and Graham BS: Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation. J Virol 2005;77:1747-1756.
54. McDonald TP, Pitt AR, Brown G, Rixon HW, and Sugrue RJ: Evidence that the respiratory syncytial virus polymerase complex associates with lipid rafts in virus-infected cells: a proteomic analysis. Virology 2004;330:147-157.
55. Jeffree CE, Rixon HW, Brown G, Aitken J, and Sugrue RJ: Distribution of the attachment (G) glycoprotein and GM1 within the envelope of mature respiratory syncytial virus filaments revealed using field emission scanning electron microscopy. Virology 2003;306:254-267.
56. Moore ML, Chi MH, Zhou W, Goleniewska K, O'Neal JF, Higginbotham JN, and Peebles RS Jr: Cutting edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity. J Immunol 2007;178:2651-2654.
57. Graham BS, Perkins MD, Wright PF, and Karzon DT: Primary respiratory syncytial virus infection in mice. J Med Virol 1988;26:153-162.
58. Thomas S, Preda-Pais A, Casares S, and Brumeanu TD: Analysis of lipid rafts in T cells. Mol Immunol 2004;41:399-409.
59. Yang H, Yogeeswaran G, Bukowski JF, and Welsh RM: Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice. Nat Immun Cell Growth Regul 1985;4:21-39.
60. Arase H, Saito T, Phillips JH, and Lanier LL: Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol 2001;167:1141-1144.
61. Prince GA, Horswood RL, Berndt J, Suffin SC, and Chanock RM: Respiratory syncytial virus infection in inbred mice. Infect Immun 1979;26:764-766.
62. Carlyle JR, Mesci A, Ljutic B, et al.: Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J Immunol 2006;176:7511-7524.